| Patents for C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group (11,963) |
|---|
| 03/26/2003 | CN1405157A Novel diazo alcoholic antifungal compound and its salt |
| 03/26/2003 | CN1103763C Process for preparation of substituted pyrimidines |
| 03/25/2003 | CA2254273C Preparation of substituted isoserine esters using metal alkoxides and .beta.-lactams |
| 03/25/2003 | CA2071717C Antipsychotic benzodioxan derivatives |
| 03/20/2003 | WO2003022994A2 Inhibition by 3-deoxyflavonoids of t-lymphocyte activation and therapies related thereto |
| 03/20/2003 | WO2003022841A1 Intermediates for preparing neuraminidase inhibitor conjugates |
| 03/20/2003 | WO2002098363A3 NON-PEPTIDE GnRH AGENTS, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR THEIR USES, AND PROCESSES FOR PREPARING THEM |
| 03/20/2003 | WO2002074758A3 Novel amines as histamine-3 receptor ligands and their therapeutic applications |
| 03/20/2003 | US20030055272 Antileukemia and antitumor agents |
| 03/20/2003 | US20030055084 Pharmaceutical compounds and methods of use thereof |
| 03/20/2003 | US20030055068 Pyrazole compounds useful as protein kinase inhibitors |
| 03/20/2003 | US20030055055 For inducing and maintaining anesthesia, sedation and muscle relaxation, as well as for combating febrile convulsions in children |
| 03/20/2003 | US20030055044 Administering pyrazole derivative for inhibiting GSK-3 or Aurora activity in a patient |
| 03/20/2003 | US20030052310 Perfluorinated amide salts and their uses as ionic conducting materials |
| 03/19/2003 | EP1293506A1 New 1-(1-(Hetero)aryl-1-perhydroxyalkylmethyl)-Piperazine derivatives, process for their preparation and pharmaceutical compositions containing the same |
| 03/12/2003 | EP1289955A1 Piperidines for use as orexin receptor antagonists |
| 03/12/2003 | EP0923575B1 Cyclic ether compounds as sodium channel modulators |
| 03/12/2003 | EP0724569B1 Process for the preparation of an oxirane, aziridine or cyclopropane |
| 03/11/2003 | US6531497 Epothilone derivatives and their synthesis and use |
| 03/06/2003 | WO2003018008A1 Apo ai expression accelerating agent |
| 03/06/2003 | WO2002072570A3 Non-imidazole compounds as histamine h3 antagonists |
| 03/06/2003 | US20030045531 Antileukemia and antitumor agents |
| 03/06/2003 | US20030045528 Antibacterial and antiprotozoal agents |
| 03/05/2003 | EP1287011A1 Hygromycin a derivatives for the treatment of bacterial and protozoal infections |
| 03/05/2003 | EP1286990A1 Stolonoxides |
| 03/05/2003 | EP1286967A1 Cyclohexane derivatives and their use as therapeutic agents |
| 03/05/2003 | EP1119560B1 Naphthopyrans annelated in c5-c6, their preparation and compositions and (co) polymer matrices containing them |
| 03/05/2003 | EP0942901B1 Cyclic imines as pesticides |
| 03/04/2003 | US6528538 Cyclic compounds useful in the treatment of dyslipidaemia, atherosclerosis and diabetes, pharamaceutical compositions and preparation process |
| 03/04/2003 | US6528510 HIV protease inhibitors |
| 02/27/2003 | WO2003016306A1 Hiv inhibiting pyrimidines derivatives |
| 02/27/2003 | WO2003016275A1 Antiviral agent |
| 02/27/2003 | WO2003016265A1 Cyclic compound and ppar agonist |
| 02/27/2003 | WO2002092588A3 Aromatic sulfone hydroxamates and their use as protease inhibitors |
| 02/27/2003 | US20030040084 Macrolide analogs |
| 02/26/2003 | EP1285919A1 C10 Carbonate substituted taxanes as antitumor agents |
| 02/26/2003 | EP1285918A1 C7 Ester substituted taxanes as antitumor agents |
| 02/26/2003 | EP1285902A1 Method for labeling with tritium |
| 02/26/2003 | EP1285086A2 Method for detecting a detectable product |
| 02/26/2003 | EP0941221B1 Substituted dihydrobenzofurans as pde inhibitors |
| 02/20/2003 | WO2003014105A1 Bicyclic compound, production and use as hiv inhibitors |
| 02/20/2003 | WO2003014103A1 Iodobenzopyran-4-one derivatives having fungicidal activity |
| 02/20/2003 | WO2003013503A1 C-2' methylated derivatives of paclitaxel for use as antitumour agents |
| 02/20/2003 | WO2003013502A1 Compounds which mimic the chemical and biological properties of discodermolide |
| 02/20/2003 | WO2002096516A8 Use of compositions comprising cyclooxygenase-2 selective inhibitors in combination with radiation for inhibition or prevention of cardiovascular disease |
| 02/20/2003 | US20030036653 For prophylaxis and therapy of diseases associated with herpes viruses including human cytomegalovirus, herpes simplex viruses, Epstein-Barr virus, varicella-zoster virus, human herpesviruses- 6 and -7, and Kaposi herpesvirus |
| 02/20/2003 | US20030036543 Especially as inhibitors of Aurora-2 and GSK-3, for treating diseases such as cancer, diabetes and Alzheimer's disease. |
| 02/20/2003 | CA2607992A1 Bicyclic compound, production and use thereof |
| 02/20/2003 | CA2456553A1 Compounds which mimic the chemical and biological properties of discodermolide |
| 02/20/2003 | CA2456523A1 C-2' methylated derivatives of paclitaxel for use as antitumour agents |
| 02/20/2003 | CA2451041A1 Iodobenzopyran-4-one derivatives having fungicidal activity |
| 02/19/2003 | EP0799218B1 Diaryl-2-(5h)-furanones as cox-2 inhibitors |
| 02/19/2003 | EP0690867B1 Taxanes having furyl or thienyl substituted side-chain |
| 02/19/2003 | EP0687260B1 Process for the preparation of 9-desoxotaxanes |
| 02/19/2003 | CN1101814C Novel hydroxy and polyhydroxy derivatives of coumarin, prepn. thereof and antiviral action thereof |
| 02/18/2003 | US6521764 Stable Fumagillin dicyclohexylamine salt used in veterinary medicine is reacted with an organic acid in alcoholic medium to free the salt |
| 02/18/2003 | US6521660 3′-alkyl substituted taxanes and pharmaceutical compositions containing them |
| 02/13/2003 | WO2003011873A2 Natural marine source phospholipids comprising flavonoids, polyunsaturated fatty acids and their applications |
| 02/13/2003 | WO2003011848A1 Benzoheterocycles as lipoxygenase inhitibors |
| 02/13/2003 | WO2002040462A3 Cysteine protease inhibitors |
| 02/13/2003 | CA2493888A1 Natural marine source phospholipids comprising flavonoids, polyunsaturated fatty acids and their applications |
| 02/12/2003 | EP1282614A1 Hydroxamic acid derivatives |
| 02/12/2003 | EP0926146B1 Chromene compounds |
| 02/12/2003 | CN1397148A Luminescent element material and luminescent element comprising the same |
| 02/12/2003 | CN1101392C Farnesyl protein transferase inhibiting (imidazol-5-yl)methyl-2-quindinone derivatives |
| 02/12/2003 | CN1101384C Process for preparing 1-biphenylmethylmidazole derivatives |
| 02/11/2003 | CA2047237C Chroman derivatives |
| 02/06/2003 | WO2003010141A2 Hepatitis c virus polymerase inhibitors with a heterobicyclic structure |
| 02/06/2003 | WO2003010140A2 Hepatitis c virus polymerase inhibitors with heterobicyclic structure |
| 02/06/2003 | WO2002070516A3 Cyclopropaheterocycles as non-nucleoside reverse transcriptase inhibitors |
| 02/06/2003 | WO2002059112A3 Pyrazole compounds useful as protein kinase inhibitors |
| 02/06/2003 | WO2002048134A3 Di-substituted aminomethyl chroman derivative beta-3 adrenoreceptor agonists |
| 02/06/2003 | US20030027855 Preparation of a derivative or analog of baccatin III or 10-desacetyl baccatin III having a C9 hydroxy substituent by selective reduction of the C9 keto compound |
| 02/06/2003 | US20030027847 Carboxyformylacetamide derivatives for treatment of AIDS or ARC |
| 02/05/2003 | EP0745087B1 Novel cytotoxic macrolides, their isolation from a marine sponge and their use as antitumor agents |
| 02/05/2003 | CN1100771C Phosphononooxymethyl ethers for taxame derivatives |
| 02/04/2003 | US6515151 Method for the preparation of novel sidechain-bearing taxanes and intermediates thereof |
| 02/04/2003 | US6515027 Substituted benzanilides as CCR5 receptors ligands, antiinflammatory agents and antiviral agents |
| 02/04/2003 | US6515015 Antidiabetic agents based on aryl and heteroarylacetic acids |
| 02/04/2003 | US6514934 For treating sexual dysfunctions in males and females |
| 01/31/2003 | CA2354486A1 C7 ester substituted taxanes |
| 01/31/2003 | CA2354478A1 C10 carbonate substituted taxanes |
| 01/30/2003 | WO2003007930A2 Use of sulfonyl aryl or heteroaryl hydroxamic acids and derivatives thereof as aggrecanase inhibitors |
| 01/30/2003 | US20030023100 For therapy of inflammatory and allergic reactions, drug or alcohol abuse, diarrhoea, gastritis, ulcers, cardiovascular diseases, urinary incontinence, depressions, states of shock, migranes, narcolepsy, overweight, asthma, glaucoma, etc. |
| 01/30/2003 | US20030022885 Pyrazole compounds useful as protein kinase inhibitors |
| 01/30/2003 | CA2453602A1 Use of sulfonyl aryl or heteroaryl hydroxamic acids and derivatives thereof as aggrecanase inhibitors |
| 01/29/2003 | EP1278741A1 Muscarinic agonists |
| 01/29/2003 | EP1102761B1 Cyclopentabenzofuran derivatives and their use |
| 01/29/2003 | EP0983255B1 Substituted 2-benzoyl-cyclohexane-1,3-diones |
| 01/29/2003 | EP0835243B1 Dialkyl phenyl halide-substituted keto-enols for use as herbicides and pesticides |
| 01/29/2003 | CN1100055C Piperazine and piperidine compounds |
| 01/28/2003 | US6511989 For therapy of vagal dysfunction in the heart, improving cardiac function, therapy of person susceptible to cardiac death |
| 01/28/2003 | US6511977 For preventing or treating cardiac arrhythmia or atrial arrhythmia |
| 01/28/2003 | US6511942 Animal husbandry, veterinary medicine |
| 01/23/2003 | WO2003006460A1 L-ascorbic acid-2-o-maleic acid-a-tocopherol diester 1-propanol adduct and process for producing the same |
| 01/23/2003 | WO2003006451A1 4-phenylpyran-2-one derivatives |
| 01/23/2003 | WO2003006447A2 Interaction inhibitors of tcf-4 with beta-catenin |
| 01/23/2003 | WO2003006430A1 Taxol enhancer compounds |
| 01/23/2003 | WO2002050066A3 Pyrazole compounds useful as protein kinase inhibitors |
| 01/23/2003 | CA2453175A1 Interaction inhibitors of tcf-4 with beta-catenin |